T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Tompkins Financial
TMP
$1.45B
| $593K | ﹤0.01% |
7,642
+268
| +4% | +$21.6K |
|
2302
Community Trust Bancorp
CTBI
$1.44B
| $592K | ﹤0.01% |
14,666
+259
| +2% | +$11.4K |
|
2303
iShares Biotechnology ETF
IBB
$9.77B
| $591K | ﹤0.01% |
3,614
-89
| -2% | -$13.7K |
|
2304
Enova International
ENVA
$6.52B
| $587K | ﹤0.01% |
17,162
+3,676
| +27% | +$129K |
|
2305
Acushnet Holdings
GOLF
$5.25B
| $587K | ﹤0.01% |
11,875
+487
| +4% | +$23.4K |
|
2306
West Bancorporation
WTBA
$511M
| $586K | ﹤0.01% |
21,125
+146
| +0.7% | +$3.91K |
|
2307
Purple Innovation
PRPL
$28.7M
| $585K | ﹤0.01% |
885
+202
| +30% | +$155K |
|
|
DSPG
2308
DELISTED
DSP Group Inc
DSPG
| $584K | ﹤0.01% |
39,436
+3,232
| +9% | +$48.3K |
|
2309
Ezcorp Inc
EZPW
$1.76B
| $583K | ﹤0.01% |
96,669
-28,001
| -22% | -$177K |
|
|
CNSL
2310
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $583K | ﹤0.01% |
66,306
+1,162
| +2% | +$9.34K |
|
|
DEA
2311
Easterly Government Properties
DEA
$1.18B
| $582K | ﹤0.01% |
11,042
+668
| +6% | +$35.3K |
|
|
LAND
2312
Gladstone Land Corp
LAND
$358M
| $580K | ﹤0.01% |
24,100
-1,601
| -6% | -$36.2K |
|
2313
Empire State Realty Trust
ESRT
$836M
| $579K | ﹤0.01% |
48,272
+5,087
| +12% | +$59.8K |
|
|
ILPT
2314
Industrial Logistics Properties Trust
ILPT
$611M
| $579K | ﹤0.01% |
22,139
+1,265
| +6% | +$31.8K |
|
2315
PetMed Express
PETS
$43.4M
| $579K | ﹤0.01% |
18,181
-6,998
| -28% | -$222K |
|
|
EGRX
2316
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $577K | ﹤0.01% |
13,485
-1,554
| -10% | -$64.1K |
|
|
BRG
2317
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $574K | ﹤0.01% |
56,400
-62,755
| -53% | -$608K |
|
|
YELL
2318
DELISTED
Yellow Corporation Common Stock
YELL
| $574K | ﹤0.01% |
88,159
-23,384
| -21% | -$174K |
|
|
IMGN
2319
DELISTED
Immunogen Inc
IMGN
| $573K | ﹤0.01% |
86,902
+3,116
| +4% | +$21.7K |
|
2320
Brookfield Renewable
BEPC
$6.66B
| $572K | ﹤0.01% |
13,643
-360
| -3% | -$15.3K |
|
2321
Rio Tinto
RIO
$160B
| $571K | ﹤0.01% |
6,804
| – | – |
|
2322
National Beverage
FIZZ
$2.93B
| $570K | ﹤0.01% |
12,074
+220
| +2% | +$10.7K |
|
2323
Koppers
KOP
$874M
| $569K | ﹤0.01% |
17,583
+305
| +2% | +$10.3K |
|
2324
Revolution Medicines
RVMD
$43.3B
| $569K | ﹤0.01% |
17,924
+2,049
| +13% | +$71.5K |
|
|
WIRE
2325
DELISTED
Encore Wire Corp
WIRE
| $567K | ﹤0.01% |
7,487
-988
| -12% | -$76.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.